 ThirdAge |
Genentech gets US hearing on Avastin, breast cancer
Reuters WASHINGTON, Feb 24 (Reuters) – Genentech has won a second chance to convince US regulators that its Avastin drug is a safe and effective treatment for breast cancer. The drugmaker, part of Roche Holding AG (ROG. … Roche to defend Avastin for breast cancer in June Prescriptions: F.D.A. Grants Hearing on Avastin as Treatment for Breast Cancer Genentech Gets FDA Hearing |
View full post on Health – Google News
